Pfizer’s stock has had a rough ride lately, and honestly, it’s left investors scratching their heads. As of April 14, 2025, shares are hovering around $22.18—a far cry from the high-flying days of the pandemic. But here’s the thing: this latest dip isn’t just about market jitters or macroeconomic headwinds. It’s about another blow to […]